During the past decade, Tucson Orthopaedic Institute conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 22 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 14 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tucson Orthopaedic Institute" #1 sponsor was "Endo Pharmaceuticals" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Stryker Orthopaedics" with 4 trials sponsored, "BioMimetic Therapeutics" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tucson Orthopaedic Institute" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "VertiFlex, Incorporated" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tucson Orthopaedic Institute" are "Osteoarthritis, Knee" (7 trials), "Knee Osteoarthritis" (5 trials), "Osteoarthritis" (4 trials), "Arthritis" (3 trials) and "Arthroplasty, Replacement, Hip" (3 trials). Many other conditions were trialed in "Tucson Orthopaedic Institute" in a lesser frequency.

Most popular intervention types in "Tucson Orthopaedic Institute" are "Device" (16 trials), "Drug" (14 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Microfracture" (3 trials), "tanezumab" (3 trials), "NSAID" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tucson Orthopaedic Institute" are 43 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tucson Orthopaedic Institute". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Tucson Orthopaedic Institute, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Tucson Orthopaedic Institute, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".

Tucson Orthopaedic Institute has several departments that took part in Clinical trials: "Tucson Orthopaedic Research Center" - 2 trials